|
|
||||||||
1 From the Departments of Anatomy and Neurobiology and 2 Pathology, Boston University School of Medicine, Massachusetts; and the 3 Department of Biomedical Science, Texas A&M Health Science Center, Baylor College of Dentistry, Dallas.
| Abstract |
|---|
|
|
|---|
METHODS. Effects of specific PI-3 kinase and MEK-1 inhibitors (LY294002, PD98059, respectively) were investigated in embryonic corneal epithelial tissues. Avian embryonic corneal epithelia were isolated as tissue sheets, organ cultured in the presence of these specific inhibitors, and stimulated with type I collagen. The tissues were evaluated for collagen-stimulated actin reorganization, erk-1 and -2 and PI-3 kinase activity, total filamentous actin accumulation, and collagen binding.
RESULTS. The MEK-1 inhibitor PD98059 decreased erk-1 and -2 phosphorylation and blocked actin reorganization in a dose-dependent manner. The PI-3 kinase 85-kDa subunit was decreased 25% in LY294002-treated tissue, and collagen binding also decreased significantly in tissues treated with MEK-1 and PI-3 kinase inhibitors compared with control tissues. In addition, both inhibitors blocked actin cortical mat reorganization.
CONCLUSIONS. PI-3 kinase and erk-1 and -2 signaling pathways are activated and necessary for collagen binding and integrin-mediated actin reorganization in embryonic avian corneal epithelium.
| Introduction |
|---|
|
|
|---|
It is well known that the MAP kinases can respond to a variety of extracellular signals, including osmotic stress, heat shock, cytokines, and mitogens.8 9 Two of the MAP kinases termed extracellular signalregulated protein kinases (erk-1 and erk-2; also referred to as erk-1/2) translocated to the nucleus after activation to regulate the expression of various transcription factors.8 Activation of the MAP kinase pathways has been identified as a mechanism that integrins use to regulate gene expression leading to cell shape changes during cell spreading or migration.10 11 The mitogen-activated kinase-kinase (MEK-1) inhibitor PD98059 specifically blocks the dephosphorylated form of MAP kinase-kinase-1, MEK-1, but not the activated or phosphorylated form of MEK-1. In addition, PD98059 can block erk-2.12
Corneal epithelial tissues isolated without basal lamina (-BL; Figs. 1C 1D ) respond to extracellular matrix (ECM) using an actin-dependent mechanism. The basal cell surface flattens, and the disrupted actin cortical mat (ACM) reorganizes in the presence of laminin, fibronectin, or collagen within 2 hours (Fig. 1) .13 14 15 16 17 The actin reorganization does not require new protein synthesis. The epithelia increase collagen synthesis in response to ECM stimulation but do not accumulate enough for autostimulation.13 14 15 16 17 In addition, we have demonstrated that the actin bundles have distinct configurations in the presence of different ECM molecules.18 We have also shown that this tissue reorganizes the actin cytoskeleton in response to bombesin or lysophosphatidic acid (LPA).18
|
-actinin, vinculin,
zyxin, FAK, paxillin, and tensin have been identified in these
CMAXs18
19
. The reorganization of the actin cytoskeleton
in response to ECM stimulation is orchestrated through signaling
cascades. The epithelia must be in contact with matrix molecules for a
minimum of 15 minutes for the ACM to reform. During these 15 minutes
many signaling proteins became activated.18
We also
established that tyrosine phosphorylation events are required, because
the c-Src and cell-permeable tyrosine kinase inhibitor herbimycin A
blocks actin reorganization in a dose-dependent manner. In addition, we
reported that late in the signaling cascade (6020 minutes) two of the
MAP kinase proteins (erk-1 and erk-2) become phosphorylated, and the
85-kDa subunit of PI-3 kinase appears to be upregulated in response to
collagen.18
In the current research we investigated the
role of these two signaling pathways in collagen-stimulated actin
reorganization by using specific inhibitors to block function. | Materials and Methods |
|---|
|
|
|---|
Corneal epithelial sheets were suspended at the airmedium interface by a triangular-shaped wire grid in an organ culture dish (Falcon, Lincoln Park, NJ). The height of the medium barely covered the apical surface of the tissue (Fig. 1B) . Cultures were incubated at 37°C for 24 to 28 hours in a humidified gas mixture (5% CO2 and 95% air). The control culture medium was composed of Hams F-12 medium, 1% antibiotic-antimycotic (GIBCO), and 50 µM ascorbic acid (Sigma).
Organ Culture for MAP Kinase and PI-3 Kinase Inhibition Experiments
The synthetic MAP kinase inhibitor,
2-(2'-amino-3'-methoxyphenyl)-oxanphthalen-4-one (PD98059; Calbiochem,
San Diego, CA) was used at three dosages (10, 50, and 100 µM).
Freshly isolated epithelia (-BL) were placed into five treatment
groups (n = 2030 epithelia per group): two groups with
control medium (containing 0.01% dimethyl sulfoxide [DMSO]), and
three groups treated with PD98059 (10, 50, and 100 µM). The MAP
kinase inhibitor was kept as a 1-M stock solution in DMSO. All
treatment groups were cultured overnight (1824 hours) at 37°C.
After the inhibitor treatment, epithelial sheets were stimulated with
100 µg/ml type I collagen (COL; Collaborative Research, Bedford, MA)
either with (n = 3 experiments) or without (n = 4
experiments) inhibitor for 2 hours at 37°C and compared with
stimulated (+COL) and nonstimulated control groups (NT, no treatment).
Control groups contained 0.01% DMSO.
The PI-3 kinase inhibitor, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one [also known as 2-(4-morpholinyl)-8-phenylchromone (LY294002; Calbiochem]6 was used in three concentrations (10, 50, and 100 nM). These experiments used the same protocol as described for the MAP kinase inhibitor, PD98059.
Organ culture experiments were repeated at least seven times, with 20 to 30 epithelia pooled in each treatment group. The epithelia were fixed and stained immediately for morphology (n = 10 epithelia per group) or placed in extraction buffer for sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis (n = 20 epithelia per group).
F-Actin Staining
Filamentous actin (F-actin) was visualized with rhodamine
phalloidin (Molecular Probes, Eugene, OR). Epithelia were fixed,
permeabilized, and stained with rhodamine phalloidin (1:100 dilution of
stock solution) for 30 minutes at room temperature, followed by rinses
in phosphate-buffered saline (PBS).18
Specimens were analyzed by upright confocal laser scanning microscope (CLSM; Leica, Deerfield, IL), equipped with an argon ion laser and a x50 water immersion lens (P1 Fluotar; Leica; numeric aperture, 1.0) with a working distance of 100 µm. En face images were obtained of the basal cytoplasm occupied by the ACM (Fig. 1F) . Additional epithelia were analyzed with a confocal microscope (model 510; Carl Zeiss, Thornwood, NY) equipped with one argon and two helium neon lasers with excitation wavelengths of 488, 543, and 633 nm. The tissue was analyzed with a x40 water immersion lens (PlanNeo; Zeiss; numeric aperture, 0.75) with a working distance of 330 µm and a scanning area of 230.3 µm2. Confocal images were analyzed, enhanced, and stored. Images were arranged by computer (Photoshop and Pagemaker programs; Adobe, San Jose, CA).
SDS-PAGE and Western Blot Analysis
Corneal epithelia (20 per treatment group) were isolated -BL and
treated as described previously in the organ culture
procedure.18
19
21
The Western blots were incubated with
one of the following antibodies: PI-3 kinase (250 µg/ml, Transduction
Laboratories, Lexington, KY) or phosphorylated erk-1 and -2 (350
µg/ml, Promega, Madison, WI). PI-3 kinase antibodies were diluted
1:1000 in 1% milk with PBS-Tween. The anti-phospho-erk-1 and -erk-2
antibody was diluted 1:10,000 in 1% milk with PBS-Tween. The primary
antibodies were detected with horseradish peroxidase (HRP) goat
anti-mouse or goat anti-rabbit secondary antibodies (Transduction
Laboratories) and identified with enhanced chemiluminescence (ECL,
Amersham, Arlington Heights, IL) and autoradiography. The blots were
washed with 1% Tween/Tris-buffered saline (TBS) and reprobed with
ß-tubulin as an internal loading standard.
Densitometry readings of representative Western blot analyses were analyzed by computer (NIH Image; National Institutes of Health, Bethesda, MD). Densitometry readings, expressed in optical density (OD) units, were taken of all the ß-tubulin lanes and used to equalize the loading per lane. The erk-1, erk-2, and PI-3 kinase OD values were calculated and graphed from representative Western blot analyses (Figs. 2 3) .
|
|
Quantitation of ECM Binding to Corneal Epithelia
Corneal epithelia were incubated with MAP kinase (100 µM) or
PI-3 kinase inhibitor (100 nM) and stimulated with FITC-labeled COL for
30 or 60 minutes The tissues were rinsed to remove any nonspecifically
bound COL, fixed, and stained with Texas red phalloidin. The tissues
were analyzed by confocal microscope (model 510; Zeiss). Initial data
were collected from three to four epithelia as a complete z
series (230.3-µm2 area) through the whole
tissue, recording both red and green channels simultaneously. The image
files (n = 2530 images) were projected into one image
using a program that sums all the intensity data into one file. These
projected images were electronically turned 90° (Fig. 4A
), producing xz images of the xy data set. All
pixel information was contained in these images. A densitometry
computer program from the microscope manufacturer (Zeiss) was used to
determine the average intensity (range = 0255) of the pixels
that intersected lines through the center of the tissue and at the
basal cell surface (Fig. 4A
, yellow lines). The average of data
collected from epithelia (n = 4) from each treatment group
was statistically analyzed using one-way analysis of variance.
|
| Results |
|---|
|
|
|---|
MAP Kinase and ECM-Stimulated Actin Reorganization
MAP kinases can respond to a variety of extracellular signals,
including osmotic stress, heat shock, cytokines, and
mitogens.8
9
The MAP kinase pathway has been identified as
a downstream pathway for integrins to regulate gene expression leading
to actin cytoskeletal-mediated cell shape changes including cell
spreading or migration.10
11
To determine whether the erk-1/2MAP kinase pathway was involved in collagen-stimulated actin reformation, we cultured epithelia in the presence of the MEK-1 inhibitor PD98059 for 24 hours before a 2-hour stimulation period with COL (with or without inhibitor). The inhibitor-treated epithelia were compared with parallel collagen-stimulated cultures (Figs. 2A 2B 2C) .
Single confocal sections at the ACM optical plane (Fig. 1E , arrowhead) demonstrated a dose-dependent decrease in actin filament bundles (Figs 2B 2C , arrowheads) compared with control samples (Fig. 2A) . Overall actin distribution and cell shape morphology of whole tissue did not change in the presence of PD98059. Epithelia exposed to the lowest dose (10 µM) had normal COL-stimulated actin reformation (data not shown). However, epithelia treated with higher doses did not have organized actin, and the basal surface was covered by blebs detected as punctate aggregates of actin in confocal micrographs (Figs. 2B 2C , arrowheads).
Activated erk-1/2 detected with an antibody that specifically binds phosphorylated erk-1/2 proteins increased in the presence of COL compared with the controls. The changes in actin reorganization in the presence of PD98059 were accompanied by decreases in activated erk-1 and -2 (Fig. 2D) in a dose-dependent manner. Cell lysates from A431 cells were used as positive controls on all Western blot analyses (Figs. 2 3) . Erk-2 activity was similar in the two control cell lysates. Densitometry analysis of epithelia treated with MEK inhibitor demonstrated a 5- to 10-fold decrease in active erk-2, whereas active erk-1 was decreased only 2- to 3-fold. ß-Tubulin staining (Figs. 2 3) was used to determine that the lanes were loaded equally. If the inhibitor was washed out before COL stimulation, levels of erk-1/2 activity decreased, and the ACM did not reform, indicating that the inhibitor had a long-term downstream effect on this whole tissue.
PI-3 Kinase and ACM Reorganization
Class III PI-3 kinases have been implicated in regulating cell
proliferation survival, metabolism, and cytoskeletal
organization.1
To determine whether the PI-3 kinase
cascade was involved in ECM-stimulated actin reorganization, we
cultured epithelia in the presence of LY294002 for 24 hours before COL
stimulation (2 hours, with or without the inhibitor). The morphology of
epithelia treated with LY294002 (Figs. 3B
3C)
was compared with
parallel experiments of control epithelia isolated -BL and stimulated
with COL (Fig. 3A) .
The PI-3 kinase inhibitor altered ACM reformation in a dose-dependent manner (Figs. 3A 3B 3C , arrowheads). Of note, there were no changes in overall actin distribution or cell shape of the peridermal cells or apical region of the basal cells at all dosages. At the optical plane of the ACM, there was no change in actin reorganization at the lowest dose (10 nM) compared with control tissues (data not shown). Actin formed bundles after exposure to the medium dose (50 nM, Fig. 3B , arrowheads); however, the bundles do not align from cell to cell as seen in the control samples (Fig. 3A) and ACM formation appeared to be disrupted. At the highest concentration tested (100 nM), there was a complete breakdown in actin bundle formation (Fig. 3C) . The actin cytoskeleton did not reorganize at all and had disorganized blebbing morphology (Fig. 3C , arrowheads) indicated by the punctate distribution of the F-actin.
This disruption in actin reorganization was accompanied by a decrease in the detectability of the 85-kDa PI-3 kinase subunit on Western blot analysis (Fig. 3D) . Densitometry analysis of the Western blot demonstrated a 25% decrease in the 85-kDa PI-3 kinase subunit in inhibitor-treated epithelia compared with control epithelia (Fig. 3E) . Of interest, increasing the dose did not further decrease the presence of the 85-kDa PI-3 kinase subunit. In addition, an approximately 60-kDa protein was consistently labeled with the p85 antibody. This may be a degradation product, because it also decreased in tissue treated with the PI-3 kinase inhibitor (Fig. 3D) . In washout experiments in which the inhibitor was absent during the final 2-hour COL stimulation, the presence of this subunit did not decrease substantially (data not shown), even though the actin did not reorganize (Figs. 3A 3C) . This indicates that the kinase activity was decreased even when the 85-kDa subunit was present.
Collagen Binding and F-Actin Accumulation
We have established a morphologic assay to measure the amount of
ECM binding to the basal surface of corneal epithelial
cells.18
In these experiments, the ECM protein was labeled
with FITC using a standard protocol. The FITC label did not interfere
with integrin signaling, because the epithelial tissues reorganized the
ACM in 2 hours, similar to tissues treated with unlabeled ECM
proteins.18
Control epithelia had the highest intensity levels for collagen binding
(Fig. 4B)
, when measured by image analysis (NIH
Image). There was a decrease in COL binding at the basal cell surface
(Fig. 4B , *P
0.05) in tissues treated with either
inhibitor; however, the MAP kinase inhibitor had a greater effect on
COL binding. These results were confirmed in binding studies that used
3H-labeled COL and collagen-coated beads
quantitated with a microplate fluorescence reader (Fig. 4D)
. In this
study, the 100-nM dose of LY294002 decreased collagen-coated bead
binding more than 50%, whereas a 10-fold higher dose (1 µM)
decreased collagen-coated bead binding to less than 10% of that in
control tissue (Fig. 4D) . The tissues treated with 100 µM PD98059
also had reduced collagen-coated bead binding (14% of control). This
independent assay confirmed the confocal analysis demonstrating that
inhibiting these two pathways decreased collagen binding to corneal
epithelia.
A concurrent decrease in F-actin in the basal area was also observed in
tissues treated with either inhibitor (Fig. 4C
, *P
0.05). The MAP kinase inhibitor PD98059 had the least F-actin
accumulation in the basal cell area measured (Fig. 4C)
. The same
epithelial samples (n = 3 per treatment group) were used to
determine the mean F-actin accumulation in the central region of the
basal cells, by using densitometry software (Fig. 4D)
. The control
epithelia (Fig. 4D)
were saturated (mean intensity levels, 250255 OD
units) by 30 minutes, whereas the inhibitor-treated tissues were
significantly less, having mean intensity values of 160 and 170 at 30
minutes (Fig. 4D)
. However, by 60 minutes there was no difference
between groups, indicating that the F-actin polymerization was delayed
but not inhibited. Of interest, these doses of inhibitors blocked ACM
reformation or actin bundling in the basal membrane area (Figs. 3C
4C)
.
In summary, we have shown that the PI-3 kinase and MAP kinase signaling pathways are critical for actin polymerization and reorganization in the embryonic corneal epithelium. Furthermore, disrupting these signal pathways decreased the amount of collagen binding to the basal cell surface.
| Discussion |
|---|
|
|
|---|
This simple epithelial model has specialized cellcell and cellmatrix domains that are responsible for stability, differentiation, and communication from the microenvironment. Using this whole corneal epithelial model, we previously determined that the reorganization of the basal actin cytoskeleton in response to specific ECM molecules is a tyrosine phosphorylation-dependent mechanism involving signaling molecules p190 Rho-GAP, FAK, paxillin, tensin, MAP kinase (erk 1/2), and PI-3 kinase.18 In the current investigation, we further characterized the MAP kinase (erk 1/2) and PI-3 kinase pathways by using specific inhibitors for these proteins. This is the first study to show that blocking these downstream signaling pathways not only decreased actin bundle formation but also decreased collagen binding.
It has been shown in a prior study that FITC-labeled ECM molecules bound to whole floating epithelial sheets and reorganized the basal cell surface after a 3-hour incubation. Furthermore, the bound ECM could be competitively removed with only similar molecules, indicating a specific receptor subtype was used for each ECM molecule class.14 We extended these experiments and determined that 15 minutes was the minimum ECM binding time that was necessary for the cells to reorganize the basal cell surface in 2 hours.18 As stated previously, the same assay was used to determine that blocking MAP kinase (erk-1/2) and PI-3 kinase pathways also decreased collagen binding.
We had previously demonstrated that PI-3 kinase protein levels increased in response to collagen, whereas MAP kinase protein levels did not increase.18 In contrast, the activated forms of erk-1/2 increased slightly in response to collagen stimulation.18 FAK interacts with the phospholipid-signaling pathway through PI-3 kinase.3 PI-3 kinase phosphorylates PIP (PI[4]phosphate) or PIP2 (PI[4,5]bisphosphate) at the D3 position to generate respectively, PI(3,4)P2 or PI(3,4,5)P3.25 These phospholipid byproducts have been implicated in downstream signaling of cytoskeletal reorganization through interactions with profilin, gelsolin (Fig. 5) , and Rac.26 In addition to its phosphorylation properties, PI-3 kinase can also act as a ser/thr protein kinase.26 In NIH 3T3 mouse fibroblasts, FAK was found to be associated with PI-3 kinase, and tyrosine phosphorylated the p85 subunit of PI-3 kinase in vitro (Fig. 5) . The binding affinity between FAK and PI-3 kinase increased when FAK was autophosphorylated. During cell adhesion, there was increased tyrosine phosphorylation of the p85 subunit of PI-3 kinase.27
|
Our data also support the hypothesis that epithelial cells respond to ECM through a sequence of events. We hypothesize that this sequence of cellular response includes at least four steps (Fig. 5) . The sequence can be divided into: 1) first contact, 2) signal amplification, 3) actin polymerization and contraction, and 4) integrin clustering that leads to increased ECM binding and increased tyrosine phosphorylation (Fig. 5) . First contact with ECM from the basal cell surface (note that this portion of the schematic drawing is upside down to accommodate the hypothesis) causes integrin-mediated FAK phosphorylation that in turn phosphorylates the surrounding proteins (paxillin, Fyn/shc, and Src)5 and leads to signal amplification. FAK also binds PI-3 kinase3 and is upstream of the MAP kinase pathway.5 Src phosphorylates p190RhoGAP, inactivating its GAP function that may allow RhoGTP to stay active longer, promoting further signal amplification.28 29 Activated RhoGTP binds to downstream kinases such as Rho-associated coiled coil-containing protein kinase (p160ROCK) and p140 diaphanous (p140Dia) to increase the third step, actin polymerization and contraction (Fig. 5) .30 31 We hypothesize that actin reorganization assists integrin clustering, allowing more ECM binding that increases FAK phosphorylation and other signal transduction events (Fig. 5) .
This sequence of signaling events is supported by data collected from the embryonic corneal epithelial model showing that ECM proteins bind to the basal surface in clusters gradually. The ECM clusters become larger and brighter with time but are not uniform (Fig. 4) . Tyrosine phosphorylation of the signaling proteins also increases gradually. For example, FAK phosphorylation may not be detectable until 15 minutes after stimulation.18
Additional evidence for the hypothesis is that decreasing Rho protein levels in corneal epithelia prevented bleb retraction and actin bundle reorganization but did not completely abolish tyrosine phosphorylation of integrin-mediated signaling proteins. However, decreasing Rho diminished tyrosine phosphorylation, which indicates that Rho was necessary for amplification of the signal initiated by ECMintegrin interactions. Of note, decreasing Raf protein levels did not block ACM reorganization or tyrosine phosphorylation.32 The present research demonstrated that inhibiting MEK 1 blocked actin reorganization, and therefore the MAP kinase pathway could be stimulated with multiple upstream alternative pathways (for example, the PI-3 kinase and/or the Ras-Raf pathway, Fig. 5 ).
In conclusion, the data recorded in this study support the current signaling hypothesis (Fig. 5) that ECM binding to integrins initiates a tyrosine phosphorylation-dependent pathway. When MAP kinase or PI-3 kinase was inhibited, actin reorganization was blocked. We also established an in vitro whole-tissue culture system that was responsive to ECM stimulation and could be readily used to determine the role of signaling molecules in actin cytoskeletal reorganization and ECM binding. Future studies will concentrate on delineating other specific proteins and their interactions in the signaling cascade with the overall objective of achieving an understanding of the role of matrix, integrins, and/or other receptor molecules in corneal epithelial cell biology.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication November 19, 1999; revised March 20 and June 14, 2000; accepted July 5, 2000.
Commercial relationships policy: N.
Corresponding author: Kathy Kay Hartford Svoboda, Department of Biomedical Sciences, Texas A&M Health Science Center, Baylor College of Dentistry, 3302 Gaston Avenue, Dallas, TX 75246. ksvoboda{at}tambcd.edu
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Chandrasekar, S. Mohanam, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and Jasti. S. Rao Glial Cell-induced Endothelial Morphogenesis Is Inhibited by Interfering with Extracellular Signal-regulated Kinase Signaling Clin. Cancer Res., June 1, 2003; 9(6): 2342 - 2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Reenstra, D. L. Orlow, and K. K. H. Svoboda ECM-Stimulated Signaling and Actin Reorganization in Embryonic Corneal Epithelia Are Rho Dependent Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3181 - 3189. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |